First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

Single-agent cetuximab is safe and active in elderly patients with advanced colorectal cancer (CRC). A cetuximab–capecitabine combination has not previously been tested in elderly patients with advanced CRC. MATERIAL AND METHODS. Sixty-six patients with advanced CRC were treated with cetuximab as a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sastre, Javier, Grávalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares-Ayerbes, Manuel, Marcuello, Eugenio, Manzano, José L., Benavides, Manuel, Hidalgo, Manuel, Díaz-Rubio, Eduardo, Aranda, Enrique
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2012
Témata:
Gastrointestinal Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3316919/
https://ncbi.nlm.nih.gov/pubmed/22363067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky